ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,659Medicare Part D Prescriptions Filled, Including Refills

Rank: 50 out of 1155

$561K Total Retail Price of All Prescriptions

Rank: 27 out of 1155

473 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

19% of this provider’s 473 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

22% of this provider’s 473 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 6,400 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
HYDROCODONE-ACETAMINOPHEN 507 308 S3 1 4
OMEPRAZOLE 387 228 2 5
AMLODIPINE BESYLATE 306 236 3 6
LISINOPRIL 281 210 4 1
LEVOTHYROXINE SODIUM 247 203 5 2
ZOLPIDEM TARTRATE 243 150 6 21
OXYCODONE HCL 233 107 S2 7 23
SIMVASTATIN 233 160 7 3
PRAVASTATIN SODIUM 223 177 9 20
FUROSEMIDE 202 122 10 8
HYDROCHLOROTHIAZIDE 175 132 11 9
WARFARIN SODIUM 162 136 12 11
PROAIR HFA 159 74 13 31
ATENOLOL 153 122 14 10
SERTRALINE HCL 125 82 15 24
CARISOPRODOL 124 18 R 16 99
MORPHINE SULFATE ER 122 67 S2 17 36
POTASSIUM CHLORIDE 121 97 18 16
TAMSULOSIN HCL 121 92 18 27
ADVAIR DISKUS 118 97 20 35
ATORVASTATIN CALCIUM 116 101 21 12
GABAPENTIN 116 97 21 15
METFORMIN HCL 113 88 23 7
PREDNISONE 111 83 24 40
SPIRIVA 107 63 25 49
METOPROLOL TARTRATE 102 54 26 14
TRAMADOL HCL 95 74 27 32
LOVASTATIN 90 86 28 13
MIRTAZAPINE 85 72 29 61
ROPINIROLE HCL 84 48 30 94
AZITHROMYCIN 83 51 31 57
CITALOPRAM HBR 79 28 32 19
OXYCODONE HCL-ACETAMINOPHEN 78 46 S2 33 117
MELOXICAM 75 31 34 52
METOPROLOL SUCCINATE 75 62 34 17
CRESTOR 72 44 36 34
CYCLOBENZAPRINE HCL 72 24 R 36 38
FLUOXETINE HCL 70 29 38 30
ALENDRONATE SODIUM 69 63 39 25
VENTOLIN HFA 69 28 39 84
TRAZODONE HCL 64 29 41 22
NEXIUM 62 33 42 98
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 35 43 26
COMBIVENT 59 55 44 103
FLUTICASONE PROPIONATE 59 32 44 37
ENDOCET 56 24 S2 46 126
SYMBICORT 55 32 47 190
CYMBALTA 53 11 48 46
LOSARTAN POTASSIUM 52 45 49 18
OXYCONTIN 50 20 S2 50 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 19, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.